研究尚不能证明药用大麻对治疗精神疾病有效
Medicinal Cannabis Not Proven in Mental Health

研究尚不能证明药用大麻对治疗精神疾病有效

Medicinal Cannabis Not Proven in Mental Health

00:00

研究尚不能证明药用大麻对治疗精神疾病有效

Medicinal Cannabis Not Proven in Mental Health

2019-11-07

澳大利亚研究人员表示,尚无充足证据表明药用大麻有助于治疗焦虑症、抑郁症和精神错乱等精神疾病。他们补充道,在给患者使用药用大麻进行治疗时,医生应该慎重考虑。


澳大利亚研究人员表示,尚无充足证据表明药用大麻有助于治疗焦虑症、抑郁症和精神错乱等精神疾病。
Researchers in Australia say evidence is weak as to whether medicinal cannabis treatments can help with mental illnesses such as anxiety, depression and psychosis.

他们补充道,在给患者使用药用大麻进行治疗时,医生应该慎重考虑。
They add that doctors should be very careful when deciding to give the treatments to patients.

研究人员验证了此前有关药用大麻素对六种精神疾病功效的科学研究。
The researchers examined scientific studies on the effects of medicinal cannabinoids on six mental health disorders.

他们发现“(这些研究)缺少证据证明药用大麻素的有效性”。
They found “a lack of evidence for their effectiveness.”

路易莎·德根哈特是澳大利亚悉尼的新南威尔士大学药物和酒精专家。
Louisa Degenhardt is a drug and alcohol expert at Australia’s University of New South Wales in Sydney.

她称,其团队的发现对美国、澳大利亚、英国和加拿大等国有重要影响。
She said her team’s findings have important effects for countries such as the United States, Australia, Britain and Canada.

在这些国家,医生会为患有某些疾病的患者提供医用大麻。
In those countries, doctors are making medical cannabis available for patients with some kinds of illnesses.

该研究结果发表在《柳叶刀精神病学》杂志上。
The study results appeared in the publication The Lancet Psychiatry.

一些退伍军人和其他患有创伤后精神紧张性障碍(PTSD)、抑郁症和焦虑症的人群表示,大麻有助于缓解他们的某些症状。
Some military veterans and others who suffer post-traumatic stress disorder (PTSD), depression and anxiety say cannabis is helpful in easing some of their symptoms.

德根哈特告诉路透社:“大麻素经常被提倡用来治疗各种精神疾病。
Degenhardt told Reuters, “Cannabinoids are often advocated as a treatment for various mental health conditions.

(但是)临床医生和消费者需要意识到相关证据很少,且质量低……”
(But) clinicians and consumers need to be aware of the low quality and quantity of evidence...”

大麻还用来治疗恶心、癫痫和脑损伤等疾病。
Cannabis is also used for conditions such as nausea, epilepsy and traumatic brain injury.

该研究并未检验大麻对治疗这些疾病的功效。
The study did not examine its effects on those conditions.

戴根哈特团队想要验证有关各种药用大麻素的所有可得证据。
Degenhardt’s team wanted to look at all available evidence for all types of medicinal cannabinoids.

他们调查了这些大麻素是否抑制或缓解了抑郁症、
They investigated whether the substances stopped or lessened symptoms of depression,

焦虑症、注意力缺陷多动障碍(ADHD)、图雷特综合征、PTSD和精神错乱等疾病。
anxiety, attention-deficit hyperactivity disorder (ADHD), Tourette syndrome, PTSD and psychosis.

他们验证了83个已发表和未发表的研究。
They examined 83 published and unpublished studies.

该研究覆盖了1980至2018年间约3,000名研究参与人员。
The research covered about 3,000 people involved in studies between 1980 and 2018.

他们发现,药用大麻会恶化精神错乱问题。
They found that medicinal cannabis made psychosis worse.

对于研究涉及的其他精神疾病,药用大麻也没有明显功效。
And it did not greatly affect any other major results for the mental illnesses studied.

汤姆·弗里曼是英国巴斯大学的成瘾和心理健康专家。
Tom Freeman is an addiction and mental health expert at Britain’s Bath University.

他没有参与这项研究。
He was not involved with the study.

但他表示,研究结果表明,现在极需对药用大麻进行高质量试验,以强化相关研究证据。
But he said the findings show an important need for high-quality tests of medical cannabis to strengthen the evidence.

乔纳森·埃文斯报道。
I’m Jonathan Evans.